Frank Morgan
Stock Analyst at RBC Capital
(0.83)
# 3,258
Out of 4,667 analysts
61
Total ratings
44.74%
Success rate
-8.15%
Average return
Main Sectors:
Stocks Rated by Frank Morgan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UHS Universal Health Services | Maintains: Sector Perform | $222 → $211 | $197.52 | +6.82% | 4 | Oct 28, 2024 | |
| HUM Humana | Maintains: Outperform | $415 → $353 | $293.97 | +20.08% | 4 | Apr 25, 2024 | |
| CI The Cigna Group | Upgrades: Outperform | $327 → $354 | $323.39 | +9.47% | 4 | Feb 5, 2024 | |
| AVAH Aveanna Healthcare Holdings | Downgrades: Sector Perform | $7 → $3 | $5.77 | -48.01% | 2 | Nov 21, 2022 | |
| AMED Amedisys | Maintains: Outperform | $165 → $139 | $90.00 | +54.44% | 5 | Oct 31, 2022 | |
| ACHC Acadia Healthcare Company | Maintains: Outperform | $84 → $94 | $39.10 | +140.41% | 1 | Aug 1, 2022 | |
| HCA HCA Healthcare | Maintains: Outperform | $256 → $249 | $333.00 | -25.23% | 3 | Jul 25, 2022 | |
| THC Tenet Healthcare | Maintains: Outperform | $104 → $99 | $151.84 | -34.80% | 2 | Jul 25, 2022 | |
| SEM Select Medical Holdings | Maintains: Outperform | $47 → $42 | $38.09 | +10.27% | 1 | Mar 7, 2022 | |
| CHE Chemed | Maintains: Outperform | $609 → $579 | $552.87 | +4.73% | 3 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $150 → $30 | $11.30 | +165.49% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $13 → $3 | $2.55 | +17.65% | 3 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $42 → $35 | $21.79 | +60.62% | 2 | Nov 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $44 → $37 | $30.78 | +20.21% | 3 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $62 → $28 | $5.13 | +445.81% | 3 | Nov 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $97 → $107 | $56.83 | +88.28% | 1 | Nov 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $13 → $9 | $8.54 | +5.39% | 1 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $137 → $124 | $120.99 | +2.49% | 1 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $96 | $144.66 | -33.64% | 3 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $113 → $111 | $161.40 | -31.23% | 3 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $473 → $476 | $600.50 | -20.73% | 1 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $65 → $41 | $12.22 | +235.52% | 2 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $7 → $8 | $5.22 | +53.26% | 4 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $102 → $104 | $98.93 | +5.12% | 1 | Jul 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $12 → $21 | $3.83 | +448.30% | 1 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $20 | $22.51 | -11.15% | 1 | Aug 10, 2018 |
Universal Health Services
Oct 28, 2024
Maintains: Sector Perform
Price Target: $222 → $211
Current: $197.52
Upside: +6.82%
Humana
Apr 25, 2024
Maintains: Outperform
Price Target: $415 → $353
Current: $293.97
Upside: +20.08%
The Cigna Group
Feb 5, 2024
Upgrades: Outperform
Price Target: $327 → $354
Current: $323.39
Upside: +9.47%
Aveanna Healthcare Holdings
Nov 21, 2022
Downgrades: Sector Perform
Price Target: $7 → $3
Current: $5.77
Upside: -48.01%
Amedisys
Oct 31, 2022
Maintains: Outperform
Price Target: $165 → $139
Current: $90.00
Upside: +54.44%
Acadia Healthcare Company
Aug 1, 2022
Maintains: Outperform
Price Target: $84 → $94
Current: $39.10
Upside: +140.41%
HCA Healthcare
Jul 25, 2022
Maintains: Outperform
Price Target: $256 → $249
Current: $333.00
Upside: -25.23%
Tenet Healthcare
Jul 25, 2022
Maintains: Outperform
Price Target: $104 → $99
Current: $151.84
Upside: -34.80%
Select Medical Holdings
Mar 7, 2022
Maintains: Outperform
Price Target: $47 → $42
Current: $38.09
Upside: +10.27%
Chemed
Mar 4, 2022
Maintains: Outperform
Price Target: $609 → $579
Current: $552.87
Upside: +4.73%
Mar 3, 2022
Downgrades: Sector Perform
Price Target: $150 → $30
Current: $11.30
Upside: +165.49%
Feb 8, 2022
Maintains: Sector Perform
Price Target: $13 → $3
Current: $2.55
Upside: +17.65%
Nov 17, 2021
Maintains: Sector Perform
Price Target: $42 → $35
Current: $21.79
Upside: +60.62%
Nov 10, 2021
Maintains: Outperform
Price Target: $44 → $37
Current: $30.78
Upside: +20.21%
Nov 9, 2021
Maintains: Sector Perform
Price Target: $62 → $28
Current: $5.13
Upside: +445.81%
Nov 4, 2021
Maintains: Outperform
Price Target: $97 → $107
Current: $56.83
Upside: +88.28%
Nov 3, 2021
Maintains: Outperform
Price Target: $13 → $9
Current: $8.54
Upside: +5.39%
Nov 3, 2021
Maintains: Outperform
Price Target: $137 → $124
Current: $120.99
Upside: +2.49%
Oct 29, 2021
Maintains: Outperform
Price Target: $100 → $96
Current: $144.66
Upside: -33.64%
Oct 29, 2021
Maintains: Sector Perform
Price Target: $113 → $111
Current: $161.40
Upside: -31.23%
Oct 15, 2021
Maintains: Outperform
Price Target: $473 → $476
Current: $600.50
Upside: -20.73%
Aug 18, 2021
Maintains: Outperform
Price Target: $65 → $41
Current: $12.22
Upside: +235.52%
Aug 9, 2021
Maintains: Sector Perform
Price Target: $7 → $8
Current: $5.22
Upside: +53.26%
Jul 29, 2021
Maintains: Outperform
Price Target: $102 → $104
Current: $98.93
Upside: +5.12%
Jun 10, 2021
Upgrades: Outperform
Price Target: $12 → $21
Current: $3.83
Upside: +448.30%
Aug 10, 2018
Maintains: Outperform
Price Target: $18 → $20
Current: $22.51
Upside: -11.15%